Search Results
Your search for Roy Decker, MD, PhD matches 3 pages
Showing 1 - 3
Roy Decker, MD, PhD, on Chemoradiation in Elderly Patients With Limited-Stage SCLC
Roy Decker, MD, PhD, of Yale University School of Medicine, discusses a National Cancer Database analysis that showed elderly patients with limited-stage small cell lung cancer can benefit from adding concurrent radiation to chemotherapy (Abstract 1010).
Stereotactic Body Radiation Therapy an Effective Option for Early-Stage Lung Cancer Patients
Stereotactic body radiation therapy (SBRT) is safe and effective in early-stage non–small cell lung cancer (NSCLC), as it confers local control in 90% or more patients with T1 disease, according to Roy Decker, MD, PhD, Associate Professor in the Department of Therapeutic Radiology at Yale Cancer...
Chemoradiotherapy Survival Benefit in Elderly Patients With Limited-Stage SCLC
In a population-based study reported in the Journal of Clinical Oncology, Corso et al found that chemoradiotherapy was associated with an overall survival benefit vs chemotherapy in elderly patients with limited-stage small cell lung cancer (SCLC). Study Details The study involved National Cancer ...
